256
Views
34
CrossRef citations to date
0
Altmetric
Original Article

Ca 125 Assay Used in Conjunction with Ca 15–3 and Tag-72 Assays for Discrimination Between Malignant and Non-Malignant Diseases of the Ovary

, , &
Pages 655-657 | Published online: 08 Jul 2009

References

  • Flam F., Einhorn N., Sjovall K. Symptomatology of ovarian cancer. Eur J Obstet Gynecol Reprod Biol 1988; 27: 53
  • Bast RC., Jr, Klug T. L, St John E., et al. A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer. N Engl J Med 1983; 309: 883
  • Einhorn N., Bast RC, Jr, Knapp R. C, Zurawski VR, Jr. Preoperative evaluation of serum CA 125 levels in patients with primary epithelial ovarian cancer. Obstet Gynecol 1986; 67: 414
  • Klug T. L, Bast RC, Jr, Niloff J. M, et al. Monoclonal antibody immunoradiometric assay for an antigenic determinant (CA 125) associated with human epithelial ovarian carcinomas. Cancer Res 1984; 44: 1048
  • Hayes D. F, Zurawski VR, Jr, Kufe DW. Comparison of circulating CA 15–3 and carcinoembryonic antigen levels in patients with breast cancer. J Clin Oncol 1986; 10: 1542
  • Klug T. L, Sattler M. A, Colcher D., Schlom J. Monoclonal antibody immunoradiometric assay for an antigenic determinant (CA 72) on a novel pancarcinoma antigen (TAG-72). Int J Cancer 1986; 38: 661

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.